Assembly Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ASMB Nasdaq 2836 www.assemblybio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Assembly Biosciences, Inc.

Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead - Jun 8th, 2026 11:03 am
Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands - Jun 5th, 2026 1:03 pm
Assembly Biosciences Announces Upcoming Investor Conference Presentations - May 28th, 2026 2:05 pm
Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares - May 26th, 2026 2:05 pm
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants - May 22nd, 2026 5:05 am
Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases - May 22nd, 2026 5:00 am
Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA Conference - May 14th, 2026 5:05 am
These Analysts Just Made A Huge Downgrade To Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Forecasts - May 13th, 2026 5:29 am
Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026 - May 13th, 2026 12:00 am
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference - May 11th, 2026 6:00 am
We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely - May 11th, 2026 5:12 am
Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 3:15 pm
Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights - May 7th, 2026 2:00 pm
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026 - Apr 9th, 2026 6:00 am
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates - Mar 19th, 2026 3:20 pm
Assembly Biosciences: Q4 Earnings Snapshot - Mar 19th, 2026 2:26 pm
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights - Mar 19th, 2026 2:05 pm
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates - Mar 5th, 2026 3:30 pm
Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates - Feb 26th, 2026 3:30 pm
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates - Feb 24th, 2026 7:55 pm